Your edit “Bitterest pill” (May 11) rightly presses on the need for urgent reforms and regulations in the pharmaceutical sector. The Central Drug Standard Control Organisation has failed in checking the quality of drugs that are available in India. It is alarming to note that drugs that are not permitted to go on sale in other countries find their way easily into the Indian market. Foreign drug-makers should not be allowed to further their interests and sales at the cost of our people. Indeed the government should examine the drawbacks in the approval procedure and investigate the violations charged in the report of the Parliamentary Committee on Health and Family Welfare.
Jacob Sahayam, Thiruvananthapuram
Letters can be mailed, faxed or e-mailed to:
The Editor, Business Standard
Nehru House, 4 Bahadur Shah Zafar Marg
New Delhi 110 002
Fax: (011) 23720201 · E-mail: letters@bsmail.in
All letters must have a postal address and telephone number
